Marrone Bio Innovations
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Marrone Bio Innovations's past years’ income statements indicate that its last revenue has increased compared to the previous period by 44210% to $44,310,000. Profit margin reached -37%. Total operating expenses were $42,650,000.

Profit Margin

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Profit margin
2012 7.14M -38.79M -543.33%
2013 14.54M -28.48M -195.89%
2014 9.13M -51.65M -565.44%
2015 9.80M -43.72M -446.16%
2016 14.04M -31.07M -221.27%
2017 18.16M -30.92M -170.23%
2018 21.22M -20.21M -95.25%
2019 29.37M -37.17M -126.56%
2020 100K -53K -53%
2021 44.31M -16.55M -37.36%

MBII Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
44.31M100K29.37M21.22M18.16M14.04M9.80M9.13M14.54M7.14M
Cost of revenue
17.06M40K13.26M10.90M10.52M9.52M9.25M9.43M10.73M4.33M
Gross profit
27.24M60K16.11M10.31M7.63M4.52M545K-302K3.80M2.80M
Operating exp.
Research and development
12.07M30K14.02M10.66M10.82M9.67M13.5M19.28M17.81M12.74M
Selling and marketing
0000000000
Total operating expenses
42.65M105K44.09M29.81M30.63M28.18M40.00M48.23M32.83M23.03M
Operating income
-14.93M-17.19M-27.98M-19.50M-22.99M-23.66M-39.45M-48.53M-29.02M-23.83M
Other income (expenses), net
-1.57M17.14M-9.19M-709K-7.93M-7.41M-4.27M-3.12M536K-14.95M
Income before tax
-16.50M-53K-37.17M-20.21M-30.92M-31.07M-43.72M-51.65M-28.48M-38.79M
Income tax expense
45K17.14M15K1.79M-201K-109K92K-219K6.53M0
Net income
-16.55M-53K-37.17M-20.21M-30.92M-31.07M-43.72M-51.65M-28.48M-38.79M
Earnings per share
Basic EPS
-0.09-0.00-0.32-0.2-1.06-1.26-1.79-2.32-3.26-2.24
Diluted EPS
-0.09-0.00-0.32-0.2-1.06-1.26-1.79-2.32-3.2-2.24
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source